Rebecca Brunette

Rebecca Brunette, PhD, currently serves as the Director of Analytical Development at BrainChild Bio since May 2024. Prior to this role, Rebecca held the position of Associate Director of Product Sciences & Characterization at GentiBio, where leadership of a team focused on the development of cell-based methods for assessing drug product functions in early-phase clinical programs was a key responsibility. Previous experience includes positions at Bristol Myers Squibb as Senior Manager of Analytical Development, where management of a Cellular Phenotyping team was crucial, and at Celgene as a Scientist in Analytical Development, leading flow cytometry method development. Rebecca's career also includes significant roles at Silverback Therapeutics, Fred Hutch, SNBL USA, and the University of Washington, showcasing a strong background in analytical biology and immunology. Educational credentials include a Ph.D. in Immunology and a BS in Microbiology, both from the University of Washington.